Journal Article (Review Article) DKFZ-2025-00138

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Digestive cancers: mechanisms, therapeutics and management.

 ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Macmillan Publishers, part of Springer Nature London

Signal transduction and targeted therapy 10(1), 24 () [10.1038/s41392-024-02097-4]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Cancers of the digestive system are major contributors to global cancer-associated morbidity and mortality, accounting for 35% of annual cases of cancer deaths. The etiologies, molecular features, and therapeutic management of these cancer entities are highly heterogeneous and complex. Over the last decade, genomic and functional studies have provided unprecedented insights into the biology of digestive cancers, identifying genetic drivers of tumor progression and key interaction points of tumor cells with the immune system. This knowledge is continuously translated into novel treatment concepts and targets, which are dynamically reshaping the therapeutic landscape of these tumors. In this review, we provide a concise overview of the etiology and molecular pathology of the six most common cancers of the digestive system, including esophageal, gastric, biliary tract, pancreatic, hepatocellular, and colorectal cancers. We comprehensively describe the current stage-dependent pharmacological management of these malignancies, including chemo-, targeted, and immunotherapy. For each cancer entity, we provide an overview of recent therapeutic advancements and research progress. Finally, we describe how novel insights into tumor heterogeneity and immune evasion deepen our understanding of therapy resistance and provide an outlook on innovative therapeutic strategies that will shape the future management of digestive cancers, including CAR-T cell therapy, novel antibody-drug conjugates and targeted therapies.

Keyword(s): Humans (MeSH) ; Immunotherapy (MeSH) ; Digestive System Neoplasms: therapy (MeSH) ; Digestive System Neoplasms: genetics (MeSH) ; Digestive System Neoplasms: pathology (MeSH) ; Digestive System Neoplasms: immunology (MeSH)

Classification:

Note: #EA:B440#

Contributing Institute(s):
  1. NWG-KKE Translationale Gastrointestinale Onkologie und präklinische Modelle (B440)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2025
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 30 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2025-01-17, last modified 2025-01-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)